Home / Health / Vaccine will be available only after trials are successful: Serum Institute

Vaccine will be available only after trials are successful: Serum Institute

Refutes media claims on vaccine to be available in 73 days

Coronavirus, vaccine, covid, drugs, tests, clinical trials

Premium

Covishield is a vaccine candidate from Oxford-AstraZeneca that is under development. SII began phase-2 trials in India last week

Sohini Das Mumbai

1 min read Last Updated : Aug 23 2020 | 11:35 PM IST

Amidst reports claiming Serum Institute of India would be ready with Covishield vaccine in 73 days, the Pune-based company on Sunday clarified that these claims were misleading.

“The government has granted us permission to only manufacture the vaccine and stockpile it for future use,” Serum Institute said on Sunday. The drugmaker said the vaccine would be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place. It said the claims surrounding Covishield's availability in the media were “conjectural”.

ALSO READ: India to have coronavirus vaccine by 2020 end, says

Topics : Coronavirus Coronavirus Vaccine Serum Institute

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in